 |
|
|
|
|
|
|
|
|
|
|
|
Current Issues in Pharmacogenomics (all day) |
|
| |
|
| |
Session Overview and Goals |
|
|
| |
Emily Winn-Deen, Ph.D.
Chair, SACGHS Pharmacogenomics Task Force |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Fundamentals of Pharmacogenomics: Origins, Definitions and Concepts |
|
|
| |
Richard M. Weinshilboum, M.D.
Professor of Molecular Pharmacology and Experimental Therapeutics
and Medicine
Mayo Clinic College of Medicine |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Discussion |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Pharmacogenomics: The Public Health Perspective |
|
|
| |
Robert L. Davis, M.D., M.P.H.
Professor, Department of Epidemiology
University of Washington School of Public Health |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q & A and Discussion |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Pharmacogenomics in the Practice of Medicine |
|
|
| |
Dr. Weinshilboum |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Discussion |
|
|
| |
Dr. Weinshilboum |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Perspectives from Industry |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Eric Lai, Ph.D.
Vice President
Discovery and Pipeline Genetics
GlaxoSmithKline |
|
|
| |
Slides
|
|
| |
|
| |
Walter Koch, Ph.D.
Vice President and Head of Research
Roche Molecular Systems |
|
|
| |
Slides
|
|
| |
|
| |
Q&A and Discussion |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Public Comments |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
HHS Efforts and Future Directions in Pharmacogenomics |
|
| |
|
| |
Rochelle Long, Ph.D.
Chief, Pharmacological & Physiological Sciences Branch
National Institute of General Medical Sciences, NIH |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Felix Frueh, Ph.D.
Associate Director for Genomics
Office of Clinical Pharmacology and Biopharmaceutics
Center for Drug Evaluation and Research, FDA |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Muin Khoury, M.D., Ph.D.
Associate Director for Genomics
Director
Office of Genomics and Disease Prevention, CDC |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Discussion |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Ethical, Legal and Social Implications of Pharmacogenomics |
|
|
| |
Patricia Deverka, M.D., M.S., M.B.E.
Fellow
Center for Genome Ethics, Law & Policy
Institute for Genome Sciences & Policy
Duke University |
|
|
| |
Slides
Webcast
Transcript
|
|
| |
|
| |
Q&A and Discussion |
|
|
| |
Webcast
Transcript
|
|
| |
|
| |
Full Committee Discussion and Next Steps for Pharmacogenomics |
|
|
| |
Facilitators: Dr. Willard and Dr. Winn-Deen |
|
|
| |
Webcast
Transcript
|
|
| |
|
|
|
Next Steps and Closing Remarks |
|
|
| |
Dr. Tuckson |
|
|
| |
Webcast
Transcript
|
|
| |
|
|
|
ADJOURN |
|
| |
|
Top of Page |
